AstraZeneca Covid-19 vaccine shows antibody levels comparable to recovered patients

Healthy volunteers in a study of a vaccine against the SARS-CoV-2 virus that AstraZeneca is developing with the University of Oxford showed levels of neutralizing antibodies comparable to those of patients who have recovered from Covid-19, according to data published Monday.